P-244 CBDCA+weekly PTXによる肺癌術後補助化学療法の安全性(術後補助療法,第49回日本肺癌学会総会号) 青木,正,竹重,麻里子,矢澤,正知 - 《Japanese Journal of Lung Cancer》 被引量: 0发表: 2008年 O-50 非小細胞肺癌に対する補助化学療法(GEM+CBDCA療法)(術後補助療法,第49回日本肺癌学会総会号)...
Adverse effects of first-line combination chemotherapy performed with paclitaxel (PTX) and carboplatin (CBDCA) (TJ regimen) on 15 ovarian cancer patients who had had no prior chemotherapy with cisplatin (CDDP) were reviewed retrospectively according to National Cancer Institute common toxicity criteria....
To determine the dose limiting toxicity (DLT) and maximum tolerated dose (MTD) of carboplatin (CBDCA) and weekly paclitaxel (PTX) for advanced n... N Ohashi,H Daga,R Nishino,... - 《Haigan》 被引量: 0发表: 2004年 First-Line Therapy for Ovarian Carcinoma: What's Next? Based on ...
This result suggests that weekly administration of PTX and intraabdominal injection of CBDCA might be beneficial in the treatment of recurrent breast cancer associated with metastatic ovarian cancer and peritoneal dissemination after operation.癌と化学療法...
進行非小細胞肺癌に対するCarboplatin+weekly Paclitaxel併用化学療法の第I/II相試験 Objective. To determine the dose limiting toxicity (DLT) and maximum tolerated dose (MTD) ofcarboplatin (CBDCA) and weekly paclitaxel (PTX) for advanced no... 大橋,信之,駄賀,晴子,西野,亮平,... - 肺癌 被引...